The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Self-micellizing solid dispersion of atorvastatin with improved physicochemical stability and oral absorption
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Statins exhibit poor aqueous solubility and chemical instability, factors that can limit drug availability at the site of infection and compromise biological activity.
“This is particularly relevant given that statins exhibit poor aqueous solubility and chemical instability, factors that can limit drug availability at the site of infection and compromise biological activity [128, 129].”
From Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies (2025) · cites this paper as [129]
Citations
Cites
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics
Dumortier, G., Grossiord, J., Agnely, F., & Chaumeil, J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9104-4 · Cited by 1,273
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,227
Self-citationHiguchi, T. (1965) · Cited by 1,145
The safety of statins in clinical practice
Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
Xu, W., Ling, P., & Zhang, T. (2013) · Journal of Drug Delivery · doi:10.1155/2013/340315 · Cited by 595
Yoshioka, M., Hancock, B. C., & Zografi, G. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600831211 · Cited by 476
wei, Z., Hao, J., Yuan, S., Li, Y., Juan, W., Sha, X., & Fang, X. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.030 · Cited by 426
Kim, M., Jin, S.-J., Kim, J.-S., Park, H. J., Song, H.-S., Neubert, R. H. H., & Hwang, S. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.01.007 · Cited by 267
Chalasani, N. (2005) · Hepatology · doi:10.1002/hep.20671 · Cited by 264
Chokshi, R. J., Sandhu, H. K., Iyer, R. M., Shah, N. H., Malick, A. W., & Zia, H. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20385 · Cited by 199
Rumondor, A. C. F., Stanford, L. A., & Taylor, L. S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9974-3 · Cited by 189
Micronization of atorvastatin calcium by antisolvent precipitation process
Zhang, H., Wang, J., Zhang, Z., Le, Y., Shen, Z., & Chen, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.02.015 · Cited by 180
Kim, J.-S., Kim, M., Park, H. J., Jin, S.-J., Lee, S., & Hwang, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.006 · Cited by 176
Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors
Desager, J., & Horsmans, Y. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631050-00003 · Cited by 167
Mortensen, K. (1992) · Europhysics Letters (EPL) · doi:10.1209/0295-5075/19/7/006 · Cited by 158
Solid State Characterization of Commercial Crystalline and Amorphous Atorvastatin Calcium Samples
Shete, G., Puri, V., Kumar, L., & Bansal, A. K. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9419-7 · Cited by 122
Choudhary, A., Rana, A. C., Aggarwal, G., Kumar, V., & Zakir, F. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.05.002 · Cited by 113
Anwar, M., Warsi, M. H., Mallick, N., Akhter, S., Gahoi, S., Jain, G. K., Talegaonkar, S., Ahmad, F. J., & Khar, R. K. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.001 · Cited by 110
Raval, A., Pillai, S. A., Bahadur, A., & Bahadur, P. (2017) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2017.01.065 · Cited by 98
Bedrov, D., Ayyagari, C., & Smith, G. D. (2006) · Journal of Chemical Theory and Computation · doi:10.1021/ct050334k · Cited by 93
Mahmoud, M. O., Aboud, H. M., Hassan, A. H., Ali, A. A., & Johnston, T. P. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.039 · Cited by 82
Singla, P., Chabba, S., & Mahajan, R. K. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.05.043 · Cited by 81
Medarević, D. P., Djuriš, J., Barmpalexis, P., Kachrimanis, K., & Ibric, S. R. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080372 · Cited by 79
Ha, E., Baek, I., Cho, W., Hwang, S., & Kim, M. (2014) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c14-00030 · Cited by 73
Shaker, M. A., Elbadawy, H. M., & Shaker, M. A. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118891 · Cited by 73
Onoue, S., Nakamura, T., Uchida, A., Ogawa, K., Yuminoki, K., Hashimoto, N., Hiza, A., Tsukaguchi, Y., Asakawa, T., Kan, T., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.014 · Cited by 69
Self-citationLainé, A.-L., Price, D. J., Davis, J. L., Roberts, D., Hudson, R., Back, K., Bungay, P. J., & Flanagan, N. J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.08.034 · Cited by 68
Alqahtani, M. S., Islam, M., Podaralla, S. K., Kaushik, R. S., Reineke, J., Woyengo, T. A., & Perumal, O. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01017 · Cited by 61
Pereira, J. M., Mejia‐Ariza, R., Ilevbare, G. A., McGettigan, H. E., Sriranganathan, N., Taylor, L. S., Davis, R. M., & Edgar, K. J. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400441d · Cited by 60
Flurbiprofen Encapsulation Using Pluronic Triblock Copolymers
Alexander, S., Cosgrove, T., Prescott, S. W., & Castle, T. C. (2011) · Langmuir · doi:10.1021/la201124c · Cited by 55
Humphries, S. E., Cooper, J. A., Dale, P., & Ramaswami, U. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.11.005 · Cited by 50
Onoue, S., Suzuki, H., Kojo, Y., Matsunaga, S., Sato, H., Mizumoto, T., Yuminoki, K., Hashimoto, N., & Yamada, S. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.05.006 · Cited by 48
Self-citationOnoue, S., Kojo, Y., Suzuki, H., Yuminoki, K., Kou, K., Kawabata, Y., Yamauchi, Y., Hashimoto, N., & Yamada, S. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.022 · Cited by 44
Self-citationJahangiri, A., Barzegar-Jalali, M., Garjani, A., Javadzadeh, Y., Hamishehkar, H., Asadpour‐Zeynali, K., & Adibkia, K. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.11.007 · Cited by 42
Naqvi, A. A., Ahmad, M., Minhas, M., Khan, K. U., Batool, F., & Ali, R. (2019) · Polymer Bulletin · doi:10.1007/s00289-019-02997-4 · Cited by 42
Kim, M., Kim, J.-S., Cho, W., Park, H. J., & Hwang, S. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.03.068 · Cited by 41
Erlandsson, B. (2002) · Polymer Degradation and Stability · doi:10.1016/s0141-3910(02)00233-1 · Cited by 38
Solubility and stability enhancement of atorvastatin by cyclodextrin complexation.
Palem, C. R., Patel, S., & Pokharkar, V. (2010) · PubMed · Cited by 35
Shilpi, D., Kushwah, V., Agrawal, A. K., & Jain, S. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2173-8 · Cited by 35
Zhang, X., Wang, H., Zhang, T., Zhou, X., & Wu, B. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.06.008 · Cited by 28
Kojo, Y., Matsunaga, S., Suzuki, H., Sato, H., Seto, Y., & Onoue, S. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.10.032 · Cited by 28
Self-citationMeasurements of the relative humidity of saturated aqueous salt solutions.
ARAI, C., HOSAKA, S., MURASE, K., & Sano, Y. (1976) · JOURNAL OF CHEMICAL ENGINEERING OF JAPAN · doi:10.1252/jcej.9.328 · Cited by 25
Suzuki, H., Moritani, T., Morinaga, T., Seto, Y., Sato, H., & Onoue, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.018 · Cited by 24
Self-citationIn vitro dissolution study of atorvastatin binary solid dispersion
Islam, M. S., Jahan, R., Tanwir, A., & Chowdhury, J. (2013) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/2231-4040.107496 · Cited by 22
Xu, M., Zhang, C., Luo, Y., Xu, L., Tao, X., Wang, Y., He, H., & Tang, X. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.752497 · Cited by 21
Yuminoki, K., Seko, F., Horii, S., Takeuchi, H., Teramoto, K., Nakada, Y., & Hashimoto, N. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24147 · Cited by 19
Desoky, E. S. E., Hassan, A. K. M., Salem, S. Y., Fadil, S. A., & Taha, A. F. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.178 · Cited by 15
Tran, P., & Park, J. (2021) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2021.1884259 · Cited by 15
Formulation development and in vitro evaluation of nanosuspensions loaded with Atorvastatin calcium
Arunkumar, N., Deecaraman, M., Rani, C., Mohanraj, K. P., & Venkateskumar, K. (2010) · Asian Journal of Pharmaceutics · doi:10.4103/0973-8398.63982 · Cited by 12
Kojo, Y., Suzuki, H., Kato, K., Kaneko, Y., Yuminoki, K., Hashimoto, N., Sato, H., Seto, Y., & Onoue, S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.053 · Cited by 11
Self-citationKojo, Y., Kobayashi, K., Matsunaga, S., Suzuki, H., Seto, Y., Sato, H., & Onoue, S. (2017) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2017.06.001 · Cited by 10
Self-citationKrauß, J., Klimt, M., Luber, M., Mayer, P., & Bracher, F. (2019) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.15.206 · Cited by 5
Flagged first, then by citations
1 of the 55 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Laufs, 2017, Atorvastatin therapy under clinical practice conditions-which LDL-C levels are achieved in patients at very high cardiovascular risk?, Dtsch. Med. Wochenschr., 1946, 1249
- Lv, 2012, Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-β-cyclodextrin complex, Pharm.- Int. J. Pharm. Sci., 67, 46
- Shah, 2008, Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation products, Rapid Commun. Mass Spectrom, Int. J. Devoted Rapid Dissem. Minute Res. Mass Spectrom., 22, 613
Cited by
Sorted by citations
Halder, S., Afrose, S., Shill, M. C., Sharmin, N., Mollick, P. P., Shuma, M. L., Muhit, M. A., & Rahman, S. M. A. (2024) · Drug Delivery · doi:10.1080/10717544.2024.2337423 · Cited by 9
Halder, S., Nasrin, F., Shill, M. C., Shuma, M. L., Sultan, M. Z., & Reza, M. S. (2025) · Scientifica · doi:10.1155/sci5/9034181 · Cited by 7
Bajwa, N., Singh, M., Naryal, S., Mahal, S., Mehta, S., Madan, J., & Baldi, A. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220822115049 · Cited by 7
e Silva, D. M., de Souza Lacerda, L., de Souza Andrioli, A., Braz, W. R., Campos, L. M., de Paiva, M. R. B., Pittella, F., Fabri, R. L., & Tavares, G. D. (2025) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.70046 · Cited by 7
“This is particularly relevant given that statins exhibit poor aqueous solubility and chemical instability, factors that can limit drug availability at the site of infection and compromise biological activity [128, 129].”
Kong, R., Xu, L., Zhu, L., & Sun, Y. (2023) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-023-01214-0 · Cited by 4
Halder, S., Afrose, S., Shill, M. C., Sharmin, N., Mollick, P. P., Shuma, M. L., Muhit, M. A., & Rahman, S. M. A. (2023) · Preprints.org · doi:10.20944/preprints202301.0170.v1 · Cited by 2
Kong, R., Xu, L., Zhu, L., & Sun, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4681358
Preparation and evaluation of a novel complex of cefixime by mechanochemical activation
Kong, R., Zhu, L., Ma, Q., Yuan, Z., & Xu, L. (2025) · Arabian Journal of Chemistry · doi:10.25259/ajc_231_2025
Halder, S., Hossain, T., Nasrin, N., Reza, R., Samdani, M. N., Shill, M. C., Chowdhury, J. A., & Reza, M. S. (2026) · Nano LIFE · doi:10.1142/s1793984426500030
Kong, R., Huangfu, L., Zhou, M., Zheng, Z., Feng, J., Chen, Q., & Dai, J. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103959
Metadata
- Authors
- Banik, S., Sato, H., & Onoue, S.
- Affiliations
- Shizuoka University (JP)
- Corresponding author
- Onoue, Satomi
- Venue
- Journal of Drug Delivery Science and Technology
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 68
- Pages
- 103065
- ISSN
- 1773-2247 (ISSN-L)
- OpenAlex
- W4206009695
- Cited by
- 10
- References
- 55
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Drug Delivery Science and Technology (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (20K07158, 20K07180)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Surfactants and Colloidal Systems
- Keywords
- atorvastatin, Pluronic F127, amphiphilic polymers, oral bioavailability, dissolution enhancement, drug stability, micellization, freeze-drying, pharmacokinetics, accelerated storage stability, poorly water-soluble drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
